Cargando…
Low Molecular Weight Dextran Sulfate (ILB(®)) Administration Restores Brain Energy Metabolism Following Severe Traumatic Brain Injury in the Rat
Traumatic brain injury (TBI) is the leading cause of death and disability in people less than 40 years of age in Western countries. Currently, there are no satisfying pharmacological treatments for TBI patients. In this study, we subjected rats to severe TBI (sTBI), testing the effects of a single s...
Autores principales: | Lazzarino, Giacomo, Amorini, Angela Maria, Barnes, Nicholas M., Bruce, Lars, Mordente, Alvaro, Lazzarino, Giuseppe, Pietro, Valentina Di, Tavazzi, Barbara, Belli, Antonio, Logan, Ann |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7555574/ https://www.ncbi.nlm.nih.gov/pubmed/32927770 http://dx.doi.org/10.3390/antiox9090850 |
Ejemplares similares
-
ILB(®), a Low Molecular Weight Dextran Sulphate, Restores Glutamate Homeostasis, Amino Acid Metabolism and Neurocognitive Functions in a Rat Model of Severe Traumatic Brain Injury
por: Lazzarino, Giacomo, et al.
Publicado: (2022) -
A phase II open label clinical study of the safety, tolerability and efficacy of ILB(®) for Amyotrophic Lateral Sclerosis
por: Logan, Ann, et al.
Publicado: (2022) -
ILB(®) Attenuates Clinical Symptoms and Serum Biomarkers of Oxidative/Nitrosative Stress and Mitochondrial Dysfunction in Patients with Amyotrophic Lateral Sclerosis
por: Lazzarino, Giacomo, et al.
Publicado: (2021) -
Severity of experimental traumatic brain injury modulates changes in concentrations of cerebral free amino acids
por: Amorini, Angela Maria, et al.
Publicado: (2016) -
Antioxidant Therapies in Traumatic Brain Injury
por: Di Pietro, Valentina, et al.
Publicado: (2020)